The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
D000328:Adult; D000368:Aged; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D003863:Depression / Q000097:blood / Q000134:cerebrospinal fluid / Q000145:classification* / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology / Q000652:urine; D003913:Dextroamphetamine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008094:Lithium / Q000097:blood; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid / Q000652:urine; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000378:metabolism; D012890:Sleep; D013961:Thyroid Gland / Q000503:physiopathology
D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D008094:Lithium; D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D003913:Dextroamphetamine; D006719:Homovanillic Acid